期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Therapeutic Perspectives of IL1 Family Members in Liver Diseases:An Update 被引量:1
1
作者 Ines Bilić Ćurčić Tomislav Kizivat +4 位作者 Ana Petrović robert smolić Ashraf Tabll George Y.Wu Martina smolić 《Journal of Clinical and Translational Hepatology》 SCIE 2022年第6期1186-1193,共8页
Interleukin(IL)1 superfamily members are a cornerstone of a variety of inflammatory processes occurring in various organs including the liver.Progression of acute and chronic liver diseases regardless of etiology depe... Interleukin(IL)1 superfamily members are a cornerstone of a variety of inflammatory processes occurring in various organs including the liver.Progression of acute and chronic liver diseases regardless of etiology depends on the stage of hepatocyte damage,the release of inflammatory cytokines and disturbances in gut microbiota.IL1 cytokines and re-ceptors can have pro-or anti-inflammatory roles,even dual functionalities conditioned by the microenvironment.Devel-oping novel therapeutic strategies to block the IL1/IL1R sign-aling pathways seems like a reasonable option.This mode of action is now exploited by anakinra and canakinumab,which are used to treat different inflammatory illnesses,and studies in liver diseases are on the way.In this mini review,we have focused on the IL1 superfamily members,given their cru-cial role in liver inflammation diseases,specifically discussing their potential role in developing new treatment strategies. 展开更多
关键词 Interleukin 1 superfamily members INFLAMMATION Acute liver dis-ease Chronic liver disease Therapy
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部